If you liked this article you might like

Abbott CEO Upbeat Despite Ongoing Merger Headaches
Merger Challenges, FDA Concerns Dampen Abbott Gains Despite Strong First Quarter
Alere Stock Surging on Latest Abbott Agreement
Can Abbott Outperform Despite Alere?